{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:12:45Z","timestamp":1792113165337,"version":"4.4.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/s12958-025-01356-5","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:15:37Z","timestamp":1741238137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Ovarian stimulation by promoting basal follicular growth"],"prefix":"10.1186","volume":"23","author":[{"given":"Masao","family":"Jinno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"1356_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1210\/er.2009-0012","volume":"30","author":"MA Edson","year":"2009","unstructured":"Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev. 2009;30:624\u2013712. https:\/\/doi.org\/10.1210\/er.2009-0012.","journal-title":"Endocr Rev"},{"key":"1356_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ando.2010.02.021","volume":"71","author":"A Gougeon","year":"2010","unstructured":"Gougeon A. Human ovarian follicular development: from activation of resting follicles to preovulatory maturation. Ann Endocrinol. 2010;71:132\u201343. https:\/\/doi.org\/10.1016\/j.ando.2010.02.021.","journal-title":"Ann Endocrinol"},{"key":"1356_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-319-31973-5_7","volume":"58","author":"N Rimon-Dahari","year":"2016","unstructured":"Rimon-Dahari N, Yerushalmi-Heinemann L, Alyagor L, Dekel N. Ovarian folliculogenesis. Results Probl Cell Differ. 2016;58:167\u201390. https:\/\/doi.org\/10.1007\/978-3-319-31973-5_7.","journal-title":"Results Probl Cell Differ"},{"key":"1356_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2014-1020","volume":"36","author":"AJW Hsueh","year":"2015","unstructured":"Hsueh AJW, Kawamura K, Cheng Y, Fauser BCJM. Intraovarian control of early folliculogenesis. Endocr Rev. 2015;36:1\u201324. https:\/\/doi.org\/10.1210\/er.2014-1020.","journal-title":"Endocr Rev"},{"key":"1356_CR5","doi-asserted-by":"publisher","first-page":"100743","DOI":"10.1016\/j.animal.2023.100743","volume":"17","author":"AJ Morton","year":"2023","unstructured":"Morton AJ, Candelaria JI, McDonnell SP, Zgodzay DP, Denicol AC. Review: Roles of follicle-stimulating hormone in preantral folliculogenesis of domestic animal: what can we learn from model species and where do we go from here? Animal. 2023;17:100743. https:\/\/doi.org\/10.1016\/j.animal.2023.100743.","journal-title":"Animal"},{"key":"1356_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/mrd.23683","volume":"90","author":"A Guzm\u00e1n","year":"2023","unstructured":"Guzm\u00e1n A, Hern\u00e1ndez-Coronado CG, Guti\u00e9rrez CG, Rosales-Torres AM. The vascular endothelial growth factor (VEGF) systems as a key regulator of ovarian follicle angiogenesis and growth. Mol Reprod Dev. 2023;90:201\u201317. https:\/\/doi.org\/10.1002\/mrd.23683.","journal-title":"Mol Reprod Dev"},{"key":"1356_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, Marca AL, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20:370\u201385. https:\/\/doi.org\/10.1093\/humupd\/dmt062.","journal-title":"Hum Reprod Update"},{"key":"1356_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12958-023-01082-w","volume":"21","author":"M Jinno","year":"2023","unstructured":"Jinno M, Tamaoka Y, Teruya K, Watanabe A, Hatakeyama N, Goda T, Kimata H, Jinno Y. Granulocyte colony-stimulating factor priming improves embryos and pregnancy rate in patients with poor ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2023;21:29. https:\/\/doi.org\/10.1186\/s12958-023-01082-w.","journal-title":"Reprod Biol Endocrinol"},{"key":"1356_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/oxfordjournals.humrep.a136365","volume":"1","author":"A Gougeon","year":"1986","unstructured":"Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod. 1986;1:81\u20137.","journal-title":"Hum Reprod"},{"key":"1356_CR10","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1007\/s43032-021-00840-8","volume":"29","author":"LRFM Paulino","year":"2022","unstructured":"Paulino LRFM, de Assis EIT, Azevedo VAN, Silva BR, da Cunha EV, Silva JRV. Why is it so difficult to have competent oocytes from in vitro cultured preantral follicles? Reprod Sci. 2022;29:3321\u201334. https:\/\/doi.org\/10.1007\/s43032-021-00840-8.","journal-title":"Reprod Sci"},{"key":"1356_CR11","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1152\/physrev.00032.2022","volume":"103","author":"EE Telfer","year":"2023","unstructured":"Telfer EE, Grosbois J, Odey YL, Rosario R, Anderson RA. Making a good egg: human oocyte health, aging, and in vitro development. Physiol Rev. 2023;103:2623\u201377. https:\/\/doi.org\/10.1152\/physrev.00032.2022.","journal-title":"Physiol Rev"},{"key":"1356_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/dbio.2001.0269","volume":"234","author":"ME Pepling","year":"2001","unstructured":"Pepling ME, Spradling AC. Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles. Dev Biol. 2001;234:339\u201351. https:\/\/doi.org\/10.1006\/dbio.2001.0269.","journal-title":"Dev Biol"},{"key":"1356_CR13","doi-asserted-by":"publisher","first-page":"103953","DOI":"10.1016\/j.jri.2023.103953","volume":"158","author":"L Yuan","year":"2023","unstructured":"Yuan L, Huang W, Bi Y, Chen S, Wang X, Li T, et al. G-CSF-mobilized peripheral blood mononuclear cells combined with platelet-rich plasma restored the ovarian function of aged rats. J Reprod Immunol. 2023;158:103953. https:\/\/doi.org\/10.1016\/j.jri.2023.103953.","journal-title":"J Reprod Immunol"},{"key":"1356_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/IJWH.S134074","volume":"9","author":"A Badawy","year":"2017","unstructured":"Badawy A, Sobh MA, Ahdy M, Abdelhafez MS. Bone marrow mesenchymal stem cell repair of cyclophosphamide-induced ovarian insufficiency in a mouse model. Int J Women\u2019s Health. 2017;9:441\u20137.","journal-title":"Int J Women\u2019s Health"},{"key":"1356_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/molehr\/gap036","volume":"15","author":"JL Tilly","year":"2009","unstructured":"Tilly JL, Telfer EE. Purification of germline stem cells from adult mammalian ovaries: a step closer towards control of the female biological clock? Mol Hum Reprod. 2009;15:393\u20138. https:\/\/doi.org\/10.1093\/molehr\/gap036.","journal-title":"Mol Hum Reprod"},{"key":"1356_CR16","doi-asserted-by":"publisher","unstructured":"McNatty KP, Hillier SG, van den Boogaard AMJ, Trimbos-Kemper TCM, Reichert LE, van Hall EV. Follicular development during the luteal phase of the human menstrual cycle. J Clin Endocrinol Metab. 1983;56:1022\u201331. https:\/\/doi.org\/10.1210\/jcem-56-5-1022.","DOI":"10.1210\/jcem-56-5-1022"},{"key":"1356_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0015-0282(16)53944-2","volume":"54","author":"A Gougeon","year":"1990","unstructured":"Gougeon A, Testart J. Influence of human menopausal gonadotropin on the recruitment of human ovarian follicles. Fertil Steril. 1990;54:848\u201352.","journal-title":"Fertil Steril"},{"key":"1356_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/ng0993-83","volume":"5","author":"CH Matthews","year":"1993","unstructured":"Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, Casagrande S, Tedeschini G, Benedetti A, Chatterjee VKK. Primary amenorrhoea and infertility due to a mutation in the \u03b2-subunit of follicle-stimulating hormone. Nat Genet. 1993;5:83\u20136.","journal-title":"Nat Genet"},{"key":"1356_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1210\/edrv-17-2-121","volume":"17","author":"A Gougeon","year":"1996","unstructured":"Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121\u201355.","journal-title":"Endocr Rev"},{"key":"1356_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ng0297-201","volume":"15","author":"TR Kumar","year":"1997","unstructured":"Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet. 1997;15:201\u20134.","journal-title":"Nat Genet"},{"key":"1356_CR21","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1073\/pnas.95.23.13612","volume":"95","author":"A Dierich","year":"1998","unstructured":"Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vitro: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA. 1998;95:13612\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1356_CR22","first-page":"3748","volume":"82","author":"K Oktay","year":"1997","unstructured":"Oktay K, Briggs D, Gosden RG. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab. 1997;82:3748\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"1356_CR23","first-page":"800","volume":"69","author":"K Shima","year":"1987","unstructured":"Shima K, Kitayama S, Nakano R. Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle. Obstet Gynecol. 1987;69:800\u20136.","journal-title":"Obstet Gynecol"},{"key":"1356_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/383531a0","volume":"383","author":"J Dong","year":"1996","unstructured":"Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 1996;383:531\u20135.","journal-title":"Nature"},{"key":"1356_CR25","doi-asserted-by":"publisher","first-page":"39523","DOI":"10.1074\/jbc.M007428200","volume":"50","author":"F Otsuka","year":"2000","unstructured":"Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem. 2000;50:39523\u20138.","journal-title":"J Biol Chem"},{"key":"1356_CR26","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1096\/fj.12-223412","volume":"27","author":"Y Cheng","year":"2013","unstructured":"Cheng Y, Kawamura K, Takae S, Deguchi M, Yang Q, Kuo C, Hsueh AJ. Oocyte-derived R-spondin2 promotes ovarian follicle development. FASEB J. 2013;27:2175\u201384.","journal-title":"FASEB J"},{"key":"1356_CR27","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1210\/endo.141.10.7732","volume":"141","author":"UA Vitt","year":"2000","unstructured":"Vitt UA, McGee EA, Hayashi M, Hsueh AJ. In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology. 2000;141:3814\u201320.","journal-title":"Endocrinology"},{"key":"1356_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1210\/er.2003-0007","volume":"25","author":"S Shimasaki","year":"2004","unstructured":"Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev. 2004;25:72\u2013101. https:\/\/doi.org\/10.1210\/er.2003-0007.","journal-title":"Endocr Rev"},{"key":"1356_CR29","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/ncomms7934","volume":"6","author":"C Liu","year":"2015","unstructured":"Liu C, Peng J, Matzuk MM, Yao HH-C. Lineage specification of ovarian theca cells requires multicellular interactions via oocyte and granulosa cells. Nat Commun. 2015;6:6934. https:\/\/doi.org\/10.1038\/ncomms7934.","journal-title":"Nat Commun"},{"key":"1356_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/77033","volume":"25","author":"SM Galloway","year":"2000","unstructured":"Galloway SM, McNatty KP, Cambridge LM, et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet. 2000;25:279\u201383.","journal-title":"Nat Genet"},{"key":"1356_CR31","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1093\/humrep\/deq275","volume":"25","author":"O Oktem","year":"2010","unstructured":"Oktem O, Urman B. Understanding follicle growth in vivo. Hum Reprod. 2010;25:2944\u201354. https:\/\/doi.org\/10.1093\/humrep\/deq275.","journal-title":"Hum Reprod"},{"key":"1356_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1006\/dbio.2002.0592","volume":"244","author":"FG Klinger","year":"2002","unstructured":"Klinger FG, De Felici M. In vitro development of growing oocytes from fetal mouse oocytes: stage-specific regulation by stem cell factor and granulosa cells. Dev Biol. 2002;244:85\u201395. https:\/\/doi.org\/10.1006\/dbio.2002.0592.","journal-title":"Dev Biol"},{"key":"1356_CR33","doi-asserted-by":"publisher","first-page":"8060","DOI":"10.1073\/pnas.122066899","volume":"99","author":"F Otsuka","year":"2002","unstructured":"Otsuka F, Shimasaki S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc Natl Acad Sci USA. 2002;99:8060\u20135. https:\/\/doi.org\/10.1073\/pnas.122066899.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1356_CR34","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1095\/biolreprod63.6.1669","volume":"63","author":"IM Joyce","year":"2000","unstructured":"Joyce IM, Clark AT, Pendola FL, Eppig JJ. Comparison of recombinant growth differentiation factor-9 and oocyte regulation of kit ligand messenger ribonucleic acid expression in mouse ovarian follicles. Biol Reprod. 2000;63:1669\u201375.","journal-title":"Biol Reprod"},{"key":"1356_CR35","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1210\/endo.140.6.6827","volume":"140","author":"X Liu","year":"1999","unstructured":"Liu X, Andoh K, Abe Y, Kobayashi J, Yamada K, Mizunuma H, Ibuki Y. A comparative study on transforming growth factor-\u03b2 and activin A for preantral follicles from adult, immature, and diethylstilbestrol-primed immature mice. Endocrinology. 1999;140:2480\u20135.","journal-title":"Endocrinology"},{"key":"1356_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1210\/endo.140.1.6409","volume":"140","author":"H Mizunuma","year":"1999","unstructured":"Mizunuma H, Liu X, Andoh K, Abe Y, Kobayashi J, Yamada K, Yokota H, Ibuki Y, Hasegawa Y. Activin from secondary follicles causes small preantral follicles to remain dormant at the resting stage. Endocrinology. 1999;140:37\u201342.","journal-title":"Endocrinology"},{"key":"1356_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/humupd\/dmh061","volume":"11","author":"JL Juengel","year":"2005","unstructured":"Juengel JL, McNatty KP. The role of proteins of the transforming growth factor-\u03b2 superfamily in the intraovarian regulation of follicular development. Hum Reprod Update. 2005;11:144\u201361. https:\/\/doi.org\/10.1093\/humupd\/dmh061.","journal-title":"Hum Reprod Update"},{"key":"1356_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1126\/science.1193573","volume":"330","author":"M Zhang","year":"2010","unstructured":"Zhang M, Su YQ, Sugiura K, Xia G, Eppig JJ. Granulosa cell ligand NPPC and its receptor NPR2 maintain meiotic arrest in mouse oocytes. Science. 2010;330:366\u20139. https:\/\/doi.org\/10.1126\/science.1193573.","journal-title":"Science"},{"key":"1356_CR39","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","volume":"142","author":"ALL Durlinger","year":"2001","unstructured":"Durlinger ALL, Gruijters MJG, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JTJ, Grootegoed JA, Themmen APN. Anti-M\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001;142:4891\u20139.","journal-title":"Endocrinology"},{"key":"1356_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/molehr\/gah015","volume":"10","author":"C Weenen","year":"2004","unstructured":"Weenen C, Laven JSE, Von Bergh ARM, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BCJM, Themmen APN. Anti-M\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77\u201383. https:\/\/doi.org\/10.1093\/molehr\/gah015.","journal-title":"Mol Hum Reprod"},{"key":"1356_CR41","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1095\/biolreprod.103.018671","volume":"69","author":"EE Nilsson","year":"2003","unstructured":"Nilsson EE, Skinner MK. Bone morphogenetic protein-4 acts as an ovarian follicle survival factor and promotes primordial follicle development. Biol Reprod. 2003;69:1265\u201372. https:\/\/doi.org\/10.1095\/biolreprod.103.018671.","journal-title":"Biol Reprod"},{"key":"1356_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/mrd.20163","volume":"69","author":"WS Lee","year":"2004","unstructured":"Lee WS, Yoon SJ, Yoon TK, Cha KY, Lee SH, Shimasaki S, Lee S, Lee KA. Effects of bone morphogenetic protein-7 (BMP-7) on primordial follicular growth in the mouse ovary. Mol Reprod Dev. 2004;69:159\u201363. https:\/\/doi.org\/10.1002\/mrd.20163.","journal-title":"Mol Reprod Dev"},{"key":"1356_CR43","doi-asserted-by":"publisher","first-page":"7282","DOI":"10.1073\/pnas.96.13.7282","volume":"96","author":"S Shimasaki","year":"1999","unstructured":"Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S, Ueno N, Sampath K, Chang RJ, Erickson GF. A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA. 1999;96:7282\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1356_CR44","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1172\/JCI2081","volume":"101","author":"KA Vendola","year":"1998","unstructured":"Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest. 1998;101:2622\u20139.","journal-title":"J Clin Invest"},{"key":"1356_CR45","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","volume":"84","author":"S Weil","year":"1999","unstructured":"Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab. 1999;84:2951\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"1356_CR46","first-page":"200","volume":"21","author":"EA McGee","year":"2000","unstructured":"McGee EA, Hsueh AJW. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21:200\u201314.","journal-title":"Endocr Rev"},{"key":"1356_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/humupd\/dmr039","volume":"18","author":"AR Baerwald","year":"2012","unstructured":"Baerwald AR, Adams GP, Pierson RA. Ovarian antral folliculogenesis during the human menstrual cycle: a review. Hum Reprod Update. 2012;18:73\u201391. https:\/\/doi.org\/10.1093\/humupd\/dmr039.","journal-title":"Hum Reprod Update"},{"key":"1356_CR48","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1210\/jcem-50-5-819","volume":"50","author":"GS diZerega","year":"1980","unstructured":"diZerega GS, Hodgen GD. The primate ovarian cycle: suppression of human menopausal gonadotropin-induced follicular growth in the presence of the dominant follicle. J Clin Endocrinol Metab. 1980;50:819\u201325. https:\/\/doi.org\/10.1210\/jcem-50-5-819.","journal-title":"J Clin Endocrinol Metab"},{"key":"1356_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/09513590.2019.1648414","volume":"36","author":"AG Grynnerup","year":"2020","unstructured":"Grynnerup AG, L\u01ffssl K, Pilsgaard F, Bogstad JW, Pr\u00e6torius L, Zedeler A, Lunding SA, Bungum L, Andersen AN, Pinborg A. Contribution of recruitable follicles to circulating anti-M\u00fcllerian hormone levels following maximal gonadotrophin stimulation in patients with limited ovarian reserve. Gynecol Endocrinol. 2020;36:273\u20136. https:\/\/doi.org\/10.1080\/09513590.2019.1648414.","journal-title":"Gynecol Endocrinol"},{"key":"1356_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1530\/jrf.0.0940177","volume":"94","author":"GP Adams","year":"1992","unstructured":"Adams GP, Matteri RL, Kastelic JP, Ko JCH, Ginther OJ. Association between surges of follicle-stimulating hormone and the emergence of follicular waves in heifers. J Reprod Fert. 1992;94:177\u201388.","journal-title":"J Reprod Fert"},{"key":"1356_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0093-691X(94)00015-M","volume":"43","author":"GP Adams","year":"1995","unstructured":"Adams GP, Pierson RA. Bovine model for study of ovarian follicular dynamics in humans. Theriogenology. 1995;43:113\u201320.","journal-title":"Theriogenology"},{"key":"1356_CR52","doi-asserted-by":"publisher","unstructured":"Seekallu SV, Toosi BM, Rawlings NC. LH pulse frequency and the emergence and growth of ovarian antral follicular waves in the ewe during the luteal phase of the estrous cycle. Reprod Biol Endocrinol. 2009;7:78. https:\/\/doi.org\/10.1186\/1477-7827-7-78.","DOI":"10.1186\/1477-7827-7-78"},{"key":"1356_CR53","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1071\/RD10121","volume":"23","author":"TE Baby","year":"2011","unstructured":"Baby TE, Bartlewski PM. Progesterone as the driving regulatory force behind serum FSH concentrations and antral follicular development in cycling ewes. Reprod Fertil Development. 2011;23:303\u201310.","journal-title":"Reprod Fertil Development"},{"key":"1356_CR54","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0015-0282(03)00544-2","volume":"80","author":"AR Baerwald","year":"2003","unstructured":"Baerwald AR, Adams GP, Pierson RA. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril. 2003;80:116\u201322. https:\/\/doi.org\/10.1016\/S0015-0282(03)00544-2.","journal-title":"Fertil Steril"},{"key":"1356_CR55","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1095\/biolreprod.103.017772","volume":"69","author":"AR Baerwald","year":"2003","unstructured":"Baerwald AR, Adams GP, Pierson RA. Characterization of ovarian follicular wave dynamics in women. Biol Reprod. 2003;69:1023\u201331. https:\/\/doi.org\/10.1095\/biolreprod.103.017772.","journal-title":"Biol Reprod"},{"key":"1356_CR56","doi-asserted-by":"publisher","first-page":"103305","DOI":"10.1016\/j.rbmo.2023.103305","volume":"47","author":"B Ata","year":"2023","unstructured":"Ata B, La Marca A, Polyzos NP. Free your patients and yourself from day 2\u20133: start ovarian stimulation any time in freeze-all cycles. Reprod Biomed Online. 2023;47:103305. https:\/\/doi.org\/10.1016\/j.rbmo.2023.103305.","journal-title":"Reprod Biomed Online"},{"key":"1356_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/03009734.2020.1734694","volume":"125","author":"A Vaiarelli","year":"2020","unstructured":"Vaiarelli A, Climadomo D, Petriglia C, Conforti A, Alviggi C, Ubaldi N, Ledda S, Ferrero S, Rienzi L, Ubaldi FM. DuoSti - a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes. A systematic review. UPSALA J Med Sci. 2020;125:121\u201330. https:\/\/doi.org\/10.1080\/03009734.2020.1734694.","journal-title":"UPSALA J Med Sci"},{"key":"1356_CR58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/humrep\/dep366","volume":"25","author":"J Van Disseldorp","year":"2010","unstructured":"Van Disseldorp J, Lambalk CB, Kwee J, Looman CWN, Eijkemans MJC, Fauser BC, Broekmans FJ. Comparison of inter- and intra-cycle variability of anti-M\u00fcllerian hormone and antral follicle counts. Hum Reprod. 2010;25:221\u20137. https:\/\/doi.org\/10.1093\/humrep\/dep366.","journal-title":"Hum Reprod"},{"key":"1356_CR59","first-page":"1","volume":"39","author":"AL Goodman","year":"1983","unstructured":"Goodman AL, Hodgen GS. The ovarian triad of the primate menstrual cycle. Recent Prog Horm Res. 1983;39:1\u201373.","journal-title":"Recent Prog Horm Res"},{"key":"1356_CR60","first-page":"71","volume":"18","author":"BC Fauser","year":"1997","unstructured":"Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev. 1997;18:71\u2013106.","journal-title":"Endocr Rev"},{"key":"1356_CR61","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.fertnstert.2022.01.029","volume":"117","author":"R Orvieto","year":"2022","unstructured":"Orvieto R. Pretreatment: Does it improve quantity or quality? Fertil Steril. 2022;117:657\u201363. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.01.029.","journal-title":"Fertil Steril"},{"key":"1356_CR62","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1093\/humrep\/deq106","volume":"25","author":"W W\u00fcrfel","year":"2010","unstructured":"W\u00fcrfel W, Santjohanser C, Hirv K, B\u00fchl M, Meri O, Laubert I, et al. High pregnancy rates with administration of granulocyte colony-stimulating factor in ART-patients with repetitive implantation failure and lacking killer-cell immunoglobulin-like receptors. Hum Reprod. 2010;25:2151\u20133.","journal-title":"Hum Reprod"},{"key":"1356_CR63","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000363239","volume":"78","author":"HG Pala","year":"2014","unstructured":"Pala HG, Pala EE, Ulkumen BA, Aktug H, Yavasoglu A, Korkmaz HA, et al. The protective effect of granulocyte colony-stimulating factor on endometrium and ovary in a rat model of diabetes mellitus. Gynecol Obstet Invest. 2014;78:94\u2013100. https:\/\/doi.org\/10.1159\/000363239.","journal-title":"Gynecol Obstet Invest"},{"key":"1356_CR64","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3802\/jgo.2014.25.4.328","volume":"25","author":"A Akdemir","year":"2014","unstructured":"Akdemir A, Zeybek B, Akman L, Ergenoglu AM, Yeniel AO, Erbas O, et al. Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model. J Gynecol Oncol. 2014;25:328\u201333. https:\/\/doi.org\/10.3802\/jgo.2014.25.4.328.","journal-title":"J Gynecol Oncol"},{"key":"1356_CR65","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1182\/blood-2010-05-286963","volume":"117","author":"H Kojima","year":"2011","unstructured":"Kojima H, Otani A, Oishi A, Makiyama Y, Nakagawa S, Yoshimura N. Granulocyte colony-stimulating factor attenuates oxidative stress-induced apoptosis in vascular endothelial cells and exhibits functional and morphologic protective effect in oxygen-induced retinopathy. Blood. 2011;117:1091\u2013100. https:\/\/doi.org\/10.1182\/blood-2010-05-286963.","journal-title":"Blood"},{"key":"1356_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nm1199","volume":"11","author":"M Harada","year":"2005","unstructured":"Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med. 2005;11:305\u201311. https:\/\/doi.org\/10.1038\/nm1199.","journal-title":"Nat Med"},{"key":"1356_CR67","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1159\/000512367","volume":"111","author":"AMR Patel","year":"2021","unstructured":"Patel AMR, Apaijai N, Chattipakorn N, Chattipakorn SC. The protective and reparative role of colony-stimulating factors in the brain with cerebral ischemia\/reperfusion injury. Neuroendocrinology. 2021;111:1029\u201365. https:\/\/doi.org\/10.1159\/000512367.","journal-title":"Neuroendocrinology"},{"key":"1356_CR68","doi-asserted-by":"publisher","first-page":"11157","DOI":"10.3390\/ijms222011157","volume":"22","author":"Y Michailov","year":"2021","unstructured":"Michailov Y, AbuMadighem A, Lunenfeld E, Kapelushnik J, Huleihel M. Granulocyte colony-stimulating factor restored impaired spermatogenesis and fertility in an AML-chemotherapy mice model. Int J Mol Sci. 2021;22:11157. https:\/\/doi.org\/10.3390\/ijms222011157.","journal-title":"Int J Mol Sci"},{"key":"1356_CR69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.brainres.2005.07.076","volume":"1058","author":"ST Lee","year":"2005","unstructured":"Lee ST, Chu K, Jung KH, Ko SY, Kim EH, Shinn DI, et al. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res. 2005;1058:120\u20138.","journal-title":"Brain Res"},{"key":"1356_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jri.2015.01.010","volume":"108","author":"W W\u00fcrfel","year":"2015","unstructured":"W\u00fcrfel W. Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and\/or recurrent spontaneous abortions. J Reprod Immunol. 2015;108:123\u201335. https:\/\/doi.org\/10.1016\/j.jri.2015.01.010.","journal-title":"J Reprod Immunol"},{"key":"1356_CR71","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/jmcb\/mjz105","volume":"12","author":"L Hong","year":"2020","unstructured":"Hong L, Yan L, Xin Z, Hao J, Liu W, Wang S, et al. Protective effects of human umbilical cord mesenchymal stem cell-derived conditioned medium on ovarian damage. J Mol Cell Biol. 2020;12:372\u201385. https:\/\/doi.org\/10.1093\/jmcb\/mjz105.","journal-title":"J Mol Cell Biol"},{"key":"1356_CR72","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/humrep\/des354","volume":"28","author":"N L\u00e9d\u00e9e","year":"2013","unstructured":"L\u00e9d\u00e9e N, Gridelet V, Ravet S, Jouan C, Gaspard O, Wenders F, et al. Impact of follicular G-CSF quantification on subsequent embryo transfer decisions: a proof of concept study. Hum Reprod. 2013;28:406\u201313. https:\/\/doi.org\/10.1093\/humrep\/des354.","journal-title":"Hum Reprod"},{"key":"1356_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nyas.14059","volume":"1466","author":"EFM de Kruijf","year":"2020","unstructured":"de Kruijf EFM, Fibbe WE, van Pel M. Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche. Ann N Y Acad Sci. 2020;1466:24\u201338. https:\/\/doi.org\/10.1111\/nyas.14059.","journal-title":"Ann N Y Acad Sci"},{"key":"1356_CR74","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.fertnstert.2018.04.025","volume":"110","author":"S Herraiz","year":"2018","unstructured":"Herraiz S, Romeu M, Buigues A, Martinez S, Diaz-Garcia C, G\u00f3mez-Segui I, et al. Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders. Fertil Steril. 2018;110:496\u2013505. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.04.025.","journal-title":"Fertil Steril"},{"issue":"65","key":"1356_CR75","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2021.01.023","volume":"225","author":"A Buigues","year":"2021","unstructured":"Buigues A, Marchante M, de Miguel-G\u00f3mez L, Martinez J, Cervell\u00f3 I, Pellicer A, et al. Stem cell-secreted factor therapy regenerates the ovarian niche and rescues follicles. Am J Obstet Gynecol. 2021;225(65):e1-14. https:\/\/doi.org\/10.1016\/j.ajog.2021.01.023.","journal-title":"Am J Obstet Gynecol"},{"key":"1356_CR76","first-page":"473","volume":"17","author":"W W\u00fcrfel","year":"2000","unstructured":"W\u00fcrfel W. Approaches to better implantation. J Ass Reprod Genet. 2000;17:473.","journal-title":"J Ass Reprod Genet"},{"key":"1356_CR77","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1530\/REP-16-0046","volume":"151","author":"A Aleyasin","year":"2016","unstructured":"Aleyasin A, Abediasl Z, Nazari A, Sheikh M. Granulocyte colony-stimulating factor in repeated IVF failure, a randomized trial. Reproduction. 2016;151:637\u201342.","journal-title":"Reproduction"},{"key":"1356_CR78","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejogrb.2017.04.022","volume":"214","author":"MS Kamath","year":"2017","unstructured":"Kamath MS, Chittawar PB, Kirubakaran R, Mascarenhas M. Use of granulocyte-colony stimulating factor in assisted reproductive technology: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2017;214:16\u201324. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.04.022.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1356_CR79","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00404-018-4892-4","volume":"298","author":"L Zhang","year":"2018","unstructured":"Zhang L, Xu W, Fu X, Huang Q, Guo X, Zhang L, et al. Therapeutic role of granulocyte colony-stimulating factor (G-CSF) for infertile women under in vitro fertilization and embryo transfer (IVF-ET) treatment: a meta-analysis. Arch Gynecol Obstet. 2018;298:861\u201371. https:\/\/doi.org\/10.1007\/s00404-018-4892-4.","journal-title":"Arch Gynecol Obstet"},{"key":"1356_CR80","doi-asserted-by":"publisher","first-page":"CD013226","DOI":"10.1002\/14651858.CD013226.pub2","volume":"1","author":"MS Kamath","year":"2020","unstructured":"Kamath MS, Kirubakaran R, Sunkara SK. Granulocyte-colony stimulating factor administration for subfertile women undergoing assisted reproduction. Cochrane Database Syst Rev. 2020;1:CD013226. https:\/\/doi.org\/10.1002\/14651858.CD013226.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1356_CR81","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12958-023-01063-z","volume":"21","author":"L Fu","year":"2023","unstructured":"Fu L, Xu Y, Yan J, Zhang X, Li D, Zheng L. Efficacy of granulocyte colony-stimulating factor for infertility undergoing IVF: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21:34. https:\/\/doi.org\/10.1186\/s12958-023-01063-z.","journal-title":"Reprod Biol Endocrinol"},{"key":"1356_CR82","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1093\/humrep\/dep240","volume":"24","author":"F Scarpellini","year":"2009","unstructured":"Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod. 2009;24:2703\u20138.","journal-title":"Hum Reprod"},{"key":"1356_CR83","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/humrep\/den011","volume":"23","author":"SE Hiby","year":"2008","unstructured":"Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod. 2008;23:972\u20136. https:\/\/doi.org\/10.1093\/humrep\/den011.","journal-title":"Hum Reprod"},{"key":"1356_CR84","doi-asserted-by":"publisher","first-page":"e12701","DOI":"10.1111\/aji.12701","volume":"78","author":"Y Xie","year":"2017","unstructured":"Xie Y, Zhang T, Tian Z, Zhang J, Wang W, Zhang H, et al. Efficacy of intrauterine perfusion of granulocyte colony-stimulating factor (G-CSF) for infertile women with thin endometrium: a systematic review and meta-analysis. Am J Reprod Immunol. 2017;78:e12701. https:\/\/doi.org\/10.1111\/aji.12701.","journal-title":"Am J Reprod Immunol"},{"key":"1356_CR85","first-page":"416","volume":"69","author":"S Kato","year":"2024","unstructured":"Kato S, Yoshida S, Morikawa M, Miyamoto A, Habara Y, Oki M, et al. Three women with low AMH conceived by conventional infertility treatments following G-CSF priming. J Jpn Soc Reprod Med. 2024;69:416 (in Japanese).","journal-title":"J Jpn Soc Reprod Med"},{"key":"1356_CR86","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1210\/edrv-12-3-235","volume":"12","author":"PA Kelly","year":"1991","unstructured":"Kelly PA, Djiane J, Postel-Vinay M, Edery M. The prolactin\/growth hormone receptor family. Endocr Rev. 1991;12:235\u201351.","journal-title":"Endocr Rev"},{"key":"1356_CR87","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","volume":"19","author":"C Bole-Feysot","year":"1998","unstructured":"Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly P. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998;19:225\u201368.","journal-title":"Endocr Rev"},{"key":"1356_CR88","first-page":"639","volume":"17","author":"N Ben-Jonathan","year":"1996","unstructured":"Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev. 1996;17:639\u201369.","journal-title":"Endocr Rev"},{"key":"1356_CR89","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1210\/endo-128-6-2776","volume":"128","author":"E Nagy","year":"1991","unstructured":"Nagy E, Berczi I. Hypophysectomized rats depend on residual prolactin for survival. Endocrinology. 1991;128:2776\u201384.","journal-title":"Endocrinology"},{"key":"1356_CR90","doi-asserted-by":"crossref","unstructured":"McNeilly AS. Prolactin and ovarian function. In: Muller EE, MacLeod RM, eds. Neuroendocrine perspectives. Amsterdam: Elsevier, 1984;3:279\u2013316.","DOI":"10.1016\/B978-0-444-90377-8.50011-9"},{"key":"1356_CR91","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/jcem-64-2-309","volume":"64","author":"A Kauppila","year":"1987","unstructured":"Kauppila A, Chatelain P, Kirkinen P, Kivinen S, Ruokonen A. Isolated prolactin deficiency in a woman with puerperal alactogenesis. J Clin Endocrinol Metab. 1987;64:309\u201312.","journal-title":"J Clin Endocrinol Metab"},{"key":"1356_CR92","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1210\/jcem-58-3-430","volume":"58","author":"N Laufer","year":"1984","unstructured":"Laufer N, Botero-Ruiz W, DeCherney AH, Haseltine F, Polan ML, Behrman HR. Gonadotropin and prolactin levels in follicular fluid of human ova successfully fertilized in vitro. J Clin Endocrinol Metab. 1984;58:430\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"1356_CR93","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF01130780","volume":"6","author":"Y Gonen","year":"1989","unstructured":"Gonen Y, Casper RF. The influence of transient hyperprolactinemia on hormonal parameters, oocyte recovery, and fertilization rates in in vitro fertilization. J In Vitro Fertil Embryo Transf. 1989;6:155\u20139.","journal-title":"J In Vitro Fertil Embryo Transf"},{"key":"1356_CR94","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000181926","volume":"35","author":"T Oda","year":"1991","unstructured":"Oda T, Yoshimura Y, Takehara Y, Kohriyama S, Sano Y, Tanabe K, et al. Effects of prolactin on fertilization and cleavage of human oocytes. Horm Res. 1991;35:33\u20138.","journal-title":"Horm Res"},{"key":"1356_CR95","unstructured":"Evans WS, Cronin MJ, Thorner MO. Hypogonadism in hyperprolactinemia and proposed mechanisms. In: Ganong WF, Martini L, eds. Frontiers in neuroendocrinology. New York; Raven Press, 1982;7:77\u2013122."},{"key":"1356_CR96","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0015-0282(16)58452-0","volume":"66","author":"M Jinno","year":"1996","unstructured":"Jinno M, Yoshimura Y, Ubukata Y, Nakamura Y. A novel method of ovarian stimulation for in vitro fertilization: bromocriptine-rebound method. Fertil Steril. 1996;66:271\u20134.","journal-title":"Fertil Steril"},{"key":"1356_CR97","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1210\/jcem.82.11.4349","volume":"82","author":"M Jinno","year":"1997","unstructured":"Jinno M, Katsumata Y, Hoshiai T, Nakamura Y, Matsumoto K, Yoshimura Y. A therapeutic role of prolactin supplementation in ovarian stimulation for in vitro fertilization: the bromocriptine-rebound method. J Clin Endocrinol Metab. 1997;82:3603\u201311.","journal-title":"J Clin Endocrinol Metab"},{"key":"1356_CR98","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/0002-9378(79)90386-7","volume":"135","author":"IA Maslar","year":"1979","unstructured":"Maslar IA, Riddick DH. Prolactin production by human endometrium during the normal menstrual cycle. Am J Obstet Gynecol. 1979;135:751\u20134.","journal-title":"Am J Obstet Gynecol"},{"key":"1356_CR99","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1210\/jcem-62-6-1288","volume":"62","author":"LJ Heffner","year":"1986","unstructured":"Heffner LJ, Iddenden DA, Lyttle CR. Electrophoretic analyses of secreted human endometrial proteins: identification and characterization of luteal phase prolactin. J Clin Endocrinol Metab. 1986;62:1288\u201395.","journal-title":"J Clin Endocrinol Metab"},{"key":"1356_CR100","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/0002-9378(81)90237-4","volume":"140","author":"DC Daly","year":"1981","unstructured":"Daly DC, Maslar IA, Rosenberg SM, Tohan N, Riddick DH. Prolactin production by luteal phase defect endometrium. Am J Obstet Gynecol. 1981;140:587\u201391.","journal-title":"Am J Obstet Gynecol"},{"key":"1356_CR101","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/jcem-51-1-78","volume":"51","author":"IA Maslar","year":"1980","unstructured":"Maslar IA, Kaplan BM, Luciano AA, Riddick DH. Prolactin production by the endometrium of early human pregnancy. J Clin Endocrinol Metab. 1980;51:78\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"1356_CR102","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/0002-9378(86)90306-6","volume":"155","author":"Y Ying","year":"1986","unstructured":"Ying Y, Randolph JF, Maier DB, Kuslis ST, Chapitis J, Riddick DH. Uterine fluid and prolactin secretion in the ovulating cynomolgus monkey. Am J Obstet Gynecol. 1986;155:677\u201380.","journal-title":"Am J Obstet Gynecol"},{"key":"1356_CR103","first-page":"541","volume":"45","author":"N Moride","year":"2000","unstructured":"Moride N, Nakagawa K, Tsutsumi Y, Yamashita M, Matsumoto M, Komatsu J, Yamano S, Aono T. Does the bromocriptine-rebound method improve embryo quality? Jpn J Fertil Steril. 2000;45:541 (in Japanese).","journal-title":"Jpn J Fertil Steril"},{"key":"1356_CR104","unstructured":"Moride N, Nakagawa K, Tsutsumi Y, Yamashita M, Matsumoto M, Komatsu J, Yamano S, Aono T. Does the bromocriptine-rebound method improve embryo quality? Acta Obst Gynaec Jpn 2001;53:417(S-343). (in Japanese)"},{"key":"1356_CR105","unstructured":"Nakamura M, Kawauchi H, Fujita K, Takei E, Motohashi E, Ishikawa M, Nishijima M. Usefulness of the bromocriptine-rebound method in IVF treatment. Annual Meeting of Japan Fertilization Implantation Society; 2002 Oct 5; Gifu City, Japan."},{"key":"1356_CR106","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/1389450054021873","volume":"6","author":"MC Thomas","year":"2005","unstructured":"Thomas MC, Baynes JW, Thorpe SR, Cooper ME. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr Drug Targets. 2005;6:453\u201374.","journal-title":"Curr Drug Targets"},{"key":"1356_CR107","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2174\/138161208784139747","volume":"14","author":"H Unoki","year":"2008","unstructured":"Unoki H, Yamagishi S. Advanced glycation end products and insulin resistance. Curr Pharm Design. 2008;14:987\u20139.","journal-title":"Curr Pharm Design"},{"key":"1356_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/rp.56.1.1","volume":"56","author":"P Ulrich","year":"2001","unstructured":"Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res. 2001;56:1\u201321.","journal-title":"Recent Prog Horm Res"},{"key":"1356_CR109","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1056\/NEJM198708063170605","volume":"317","author":"E Ferrannini","year":"1987","unstructured":"Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350\u20137.","journal-title":"N Engl J Med"},{"key":"1356_CR110","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595\u2013607.","journal-title":"Diabetes"},{"key":"1356_CR111","unstructured":"Patrick L. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 2002;7:276\u201391."},{"key":"1356_CR112","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.biocel.2004.03.009","volume":"36","author":"A Terman","year":"2004","unstructured":"Terman A, Brunk UT. Aging as a catabolic malfunction. Int J Biochem Cell Biol. 2004;36:2365\u201375.","journal-title":"Int J Biochem Cell Biol"},{"key":"1356_CR113","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13098-020-00614-3","volume":"12","author":"M Takeuchi","year":"2020","unstructured":"Takeuchi M. Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle. Diabetol Metab Syndr. 2020;12:105. https:\/\/doi.org\/10.1186\/s13098-020-00614-3.","journal-title":"Diabetol Metab Syndr"},{"key":"1356_CR114","doi-asserted-by":"publisher","first-page":"bqz006","DOI":"10.1210\/endocr\/bqz006","volume":"161","author":"HH Ruiz","year":"2020","unstructured":"Ruiz HH, Ramasamy R, Schmidt AM. Advanced glycation end products: building on the concept of the \u201ccommon soil\u201d in metabolic disease. Endocrinology. 2020;161:bqz006. https:\/\/doi.org\/10.1210\/endocr\/bqz006.","journal-title":"Endocrinology"},{"key":"1356_CR115","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1046\/j.1365-2362.1999.00522.x","volume":"29","author":"G Paolisso","year":"1999","unstructured":"Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D. Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest. 1999;29:758\u201369.","journal-title":"Eur J Clin Invest"},{"key":"1356_CR116","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1053\/meta.2002.33191","volume":"51","author":"TB Vanltallie","year":"2002","unstructured":"Vanltallie TB. Stress: a risk factor for serious illness. Metabolism. 2002;51:40\u20135.","journal-title":"Metabolism"},{"key":"1356_CR117","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/15622970109026799","volume":"2","author":"OM Wolkowitz","year":"2001","unstructured":"Wolkowitz OM, Epel ES, Reus VI. Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry. 2001;2:115\u201343.","journal-title":"World J Biol Psychiatry"},{"key":"1356_CR118","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1017\/S0007114500000957","volume":"83","author":"P Bjorntorp","year":"2000","unstructured":"Bjorntorp P, Rosmond R. The metabolic syndrome - a neuroendocrine disorder? Br J Nutr. 2000;83:S49\u201357.","journal-title":"Br J Nutr"},{"key":"1356_CR119","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2337\/diab.32.5.408","volume":"32","author":"M Rosenthal","year":"1983","unstructured":"Rosenthal M, Haskell WL, Solomon R, Widstrom A, Reaven GM. Demonstration of a relationship between levels of physical training and insulin-stimulated glucose utilisation in normal humans. Diabetes. 1983;32:408\u201311.","journal-title":"Diabetes"},{"key":"1356_CR120","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774\u2013800.","journal-title":"Endocr Rev"},{"key":"1356_CR121","doi-asserted-by":"publisher","first-page":"161","DOI":"10.14310\/horm.2002.1266","volume":"9","author":"M Jinno","year":"2010","unstructured":"Jinno M, Kondou K, Teruya K. Low-dose metformin improves pregnancy rate in in vitro fertilization repeaters without polycystic ovary syndrome: prediction of effectiveness by multiple parameters related to insulin resistance. Hormones (Athens). 2010;9:161\u201370.","journal-title":"Hormones (Athens)"},{"key":"1356_CR122","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","volume":"62","author":"E Diamanti-Kandarakis","year":"2005","unstructured":"Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol. 2005;62:37\u201343.","journal-title":"Clin Endocrinol"},{"key":"1356_CR123","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/humrep\/deq388","volume":"26","author":"M Jinno","year":"2011","unstructured":"Jinno M, Takeuchi M, Watanabe A, Teruya K, Hirohama J, Eguchi N, Miyazaki A. Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology. Hum Reprod. 2011;26:604\u201310.","journal-title":"Hum Reprod"},{"key":"1356_CR124","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/humrep\/det383","volume":"29","author":"Z Merhi","year":"2014","unstructured":"Merhi Z. Advanced glycation end products and their relevance in female reproduction. Hum Reprod. 2014;29:135\u201345.","journal-title":"Hum Reprod"},{"key":"1356_CR125","doi-asserted-by":"publisher","first-page":"117830","DOI":"10.1016\/j.lfs.2020.117830","volume":"255","author":"J Zhu","year":"2020","unstructured":"Zhu J, Cai Y, Long S, Chen Z, Mo Z. The role of advanced glycation end products in human infertility. Life Sci. 2020;255:117830. https:\/\/doi.org\/10.1016\/j.lfs.2020.117830.","journal-title":"Life Sci"},{"key":"1356_CR126","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12958-021-00832-y","volume":"19","author":"M Jinno","year":"2021","unstructured":"Jinno M, Nagai R, Takeuchi M, Watanabe A, Teruya K, Sugawa H, Hatakeyama N, Jinno Y. Trapa bispinosa Roxb. extract lowers advanced glycation end-products and increases live births in older patients with assisted reproductive technology: a randomized controlled trial. Reprod Biol Endocrinol. 2021;19:149. https:\/\/doi.org\/10.1186\/s12958-021-00832-y.","journal-title":"Reprod Biol Endocrinol."},{"key":"1356_CR127","doi-asserted-by":"publisher","first-page":"959830","DOI":"10.1155\/2014\/959830","volume":"2014","author":"P Adkar","year":"2014","unstructured":"Adkar P, Dongare A, Ambavada S, Bhaskar VH. Trapa bispinosa Roxb.: a review on nutritional and pharmacological aspects. Adv Pharmacol Sci. 2014;2014:959830. https:\/\/doi.org\/10.1155\/2014\/959830.","journal-title":"Adv Pharmacol Sci."},{"key":"1356_CR128","first-page":"72","volume":"2","author":"S Takeshita","year":"2015","unstructured":"Takeshita S, Yagi M, Uemura T, Yamada M, Yonei Y. Peel extract of water chestnut (Trapa bispinosa Roxb.) inhibits glycation, degrades \u03b1-dicarbonyl compound, and breaks advanced glycation end product crosslinks. Glycative Stress Res. 2015;2:72\u20139.","journal-title":"Glycative Stress Res."},{"key":"1356_CR129","unstructured":"JSOG-ART. 2018 ART data book, 2018. https:\/\/plaza.umin.ac.jp\/~jsog-art\/2018data_20201001.pdf."},{"key":"1356_CR130","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.foodchem.2014.05.083","volume":"165","author":"M Yasuda","year":"2014","unstructured":"Yasuda M, Yasutake K, Hino M, Ohwatari H, Ohmagari N, Takedomi K, Tanaka T, Nonaka G. Inhibitory effects of polyphenols from water chestnut (Trapa japonica) husk on glycolytic enzymes and postprandial blood glucose elevation in mice. Food Chem. 2014;165:42\u20139.","journal-title":"Food Chem"},{"key":"1356_CR131","doi-asserted-by":"publisher","DOI":"10.1007\/s10719-020-09957-5","author":"H Yamaguchi","year":"2020","unstructured":"Yamaguchi H, Nagai M, Sugawa H, Yasuda H, Nagai R. Development of a conventional immunochemical detection system for determination of N\u03b4-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine in methylglyoxal-modified proteins. Glycoconj J. 2020. https:\/\/doi.org\/10.1007\/s10719-020-09957-5.","journal-title":"Glycoconj J"},{"key":"1356_CR132","doi-asserted-by":"publisher","first-page":"9073451","DOI":"10.1155\/2019\/9073451","volume":"14","author":"S Kinoshita","year":"2019","unstructured":"Kinoshita S, Mera K, Ichikawa H, Shimasaki S, Nagai M, Taga Y, Iijima K, Hattori S, Fujiwara Y, Shirakawa J, Nagai R. N\u03c9-(carboxymethyl)arginine is one of the dominant advanced glycation end products in glycated collagens and mouse tissues. Oxid Med Cell Longev. 2019;14:9073451. https:\/\/doi.org\/10.1155\/2019\/9073451.","journal-title":"Oxid Med Cell Longev"},{"key":"1356_CR133","first-page":"380","volume":"40","author":"T Miyazaki","year":"1995","unstructured":"Miyazaki T, Kuji N, Sueoka K, Natori M, Kobayashi T, Nozawa S. Effect of administration of danazol on the pregnancy rate of initially unsuccessful in vitro fertilization-embryo transfer patients. Jpn J Fertil Sterl. 1995;40:380\u20135 (Japanese).","journal-title":"Jpn J Fertil Sterl"},{"key":"1356_CR134","first-page":"541","volume":"43","author":"C Tei","year":"1998","unstructured":"Tei C, Miyazaki T, Kuji N, Tanaka M, Sueoka K, Yoshimura Y. Effect of danazol on the pregnancy rate in patients with unsuccessful in vitro fertilization-embryo transfer. J Reprod Med. 1998;43:541\u20136.","journal-title":"J Reprod Med"},{"key":"1356_CR135","doi-asserted-by":"publisher","first-page":"7196","DOI":"10.3390\/ijms21197196","volume":"21","author":"M Vieri","year":"2020","unstructured":"Vieri M, Kirschner M, Tometten M, Abels A, Rolles B, Isfort S, et al. Comparable effects of the androgen derivatives danazol, oxymetholone and nandrolone on telomerase activity in human primary hematopoietic cells from patients with dyskeratosis congenita. Int J Mol Sci. 2020;21:7196. https:\/\/doi.org\/10.3390\/ijms21197196.","journal-title":"Int J Mol Sci"},{"key":"1356_CR136","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","volume":"374","author":"DM Townsley","year":"2016","unstructured":"Townsley DM, Dumitriu B, Liu D, Biancotto A, Weinstein B, Chen C, et al. Danazol treatment for telomere diseases. N Engl J Med. 2016;374:1922\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1515319.","journal-title":"N Engl J Med"},{"issue":"1","key":"1356_CR137","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/whr.2023.0013","volume":"4","author":"I C\u00f3rdova-Oriz","year":"2023","unstructured":"C\u00f3rdova-Oriz I, Kohls G, Iglesias C, Polonio AM, Chico-Sordo L, Toribio M, et al. A randomized controlled intervention trial with danazol to improve telomeric and fertility parameters in women with diminished ovarian reserve: a pilot study. Women\u2019s Health Rep. 2023;4(1):305\u201318. https:\/\/doi.org\/10.1089\/whr.2023.0013.","journal-title":"Women\u2019s Health Rep"},{"key":"1356_CR138","doi-asserted-by":"publisher","first-page":"CD000069","DOI":"10.1002\/14651858.CD000069.pub2","volume":"1","author":"E Hughes","year":"2007","unstructured":"Hughes E, Brown J, Tiffin G. Danazol for unexplained subfertility. Cochrane Database Sys Rev. 2007;1:CD000069. https:\/\/doi.org\/10.1002\/14651858.CD000069.pub2.","journal-title":"Cochrane Database Sys Rev"},{"key":"1356_CR139","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1210\/me.2010-0006","volume":"24","author":"A Sen","year":"2010","unstructured":"Sen A, Hammes SR. Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol. 2010;24:1393\u2013403. https:\/\/doi.org\/10.1210\/me.2010-0006.","journal-title":"Mol Endocrinol"},{"key":"1356_CR140","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.rbmo.2012.07.011","volume":"25","author":"M Gonz\u00e1lez-Comadran","year":"2012","unstructured":"Gonz\u00e1lez-Comadran M, Dur\u00e1n M, Sol\u00e1 I, F\u00e1bregus F, Carreras R, Checa MA. Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis. Reprod Biomed Online. 2012;25:450\u20139. https:\/\/doi.org\/10.1016\/j.rbmo.2012.07.011.","journal-title":"Reprod Biomed Online"},{"key":"1356_CR141","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/rmb2.12383","volume":"20","author":"QH Hoang","year":"2021","unstructured":"Hoang QH, Ho HS, Do HT, Nguyen TV, Nguyen HP, Le MT. Therapeutic effect of prolonged testosterone pretreatment in women with poor ovarian response: a randomized control trial. Reprod Med Biol. 2021;20:305\u201312. https:\/\/doi.org\/10.1002\/rmb2.12383.","journal-title":"Reprod Med Biol"},{"key":"1356_CR142","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/humrep\/dew028","volume":"31","author":"JK Bosdou","year":"2016","unstructured":"Bosdou JK, Venetis CA, Dafopoulos K, Zepiridis L, Chatzimeletiou K, Anifandis G, et al. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial. Hum Reprod. 2016;31:977\u201385. https:\/\/doi.org\/10.1093\/humrep\/dew028.","journal-title":"Hum Reprod"},{"key":"1356_CR143","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.rbmo.2021.05.021","volume":"43","author":"J Subir\u00e1","year":"2021","unstructured":"Subir\u00e1 J, Algaba A, V\u00e1zquez S, Das\u00ed RT, Robles GM, Fabuel SM, et al. Testosterone does not improve ovarian response in Bologna poor responders: a randomized controlled trial (TESTOPRIM). Reprod Biomed Online. 2021;43:466\u201374. https:\/\/doi.org\/10.1016\/j.rbmo.2021.05.021.","journal-title":"Reprod Biomed Online"},{"key":"1356_CR144","doi-asserted-by":"publisher","unstructured":"Polyzos NP,\u00a0Martinez F,\u00a0Blockeel C,\u00a0Gosalvez A,\u00a0De la Fuente L,\u00a0Pinborg A,\u00a0et al. Transdermal testosterone prior to ovarian stimulation for in vitro fertilization in women with poor ovarian response. A multicenter multinational double-blind placebo-controlled randomized trial (The T-TRANSPORT). Hum Reprod. 2023;38:Suppl(1):i41. June 2023, dead093.080.\u00a0https:\/\/doi.org\/10.1093\/humrep\/dead093.080","DOI":"10.1093\/humrep\/dead093.080"},{"key":"1356_CR145","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10815-016-0713-5","volume":"33","author":"M Zhang","year":"2016","unstructured":"Zhang M, Niu W, Wang Y, Xu J, Bao X, Wang L, et al. Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis. J Assist Reprod Genet. 2016;33:981\u201391. https:\/\/doi.org\/10.1007\/s10815-016-0713-5.","journal-title":"J Assist Reprod Genet"},{"key":"1356_CR146","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12958-018-0409-z","volume":"16","author":"C Chern","year":"2018","unstructured":"Chern C, Tsui K, Vitale SG, Chen S, Wang P, Cianci A, et al. Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study. Reprod Biol Endocrinol. 2018;16:90. https:\/\/doi.org\/10.1186\/s12958-018-0409-z.","journal-title":"Reprod Biol Endocrinol"},{"key":"1356_CR147","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/1471-0528.17045","volume":"129","author":"Z Wang","year":"2021","unstructured":"Wang Z, Yang A, Bao H, Wang A, Deng X, Xue D, et al. Effect of dehydroepiandrosterone administration before in vitro fertilization on the live birth rate in poor ovarian responders according to the Bologna criteria: a randomised controlled trial. BJOG. 2021;129:1030\u20138. https:\/\/doi.org\/10.1111\/1471-0528.17045.","journal-title":"BJOG"},{"key":"1356_CR148","doi-asserted-by":"publisher","first-page":"653857","DOI":"10.3389\/fendo.2021.653857","volume":"12","author":"AR Neves","year":"2021","unstructured":"Neves AR, Montoya-Botero P, Polyzos NP. The role of androgen supplementation in women with diminished ovarian reserve: time to randomize, not meta-analyze. Front Endocrinol (Lausanne). 2021;12:653857. https:\/\/doi.org\/10.3389\/fendo.2021.653857.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1356_CR149","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/humrep\/deab106","volume":"36","author":"L Atkinson","year":"2021","unstructured":"Atkinson L, Martin F, Sturmey RG. Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon? Hum Reprod. 2021;36:1737\u201350. https:\/\/doi.org\/10.1093\/humrep\/deab106.","journal-title":"Hum Reprod."},{"key":"1356_CR150","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.fertnstert.2020.07.031","volume":"114","author":"AJW Hsueh","year":"2020","unstructured":"Hsueh AJW, Kawamura K. Hippo signaling disruption and ovarian follicle activation in infertile patients. Fertil Steril. 2020;114:458\u201364. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.07.031.","journal-title":"Fertil Steril"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01356-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01356-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01356-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T16:56:25Z","timestamp":1741280185000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-025-01356-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01356-5","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patients. The study was approved by the Ethics Committees of Women\u2019s Clinic Jinno. Clinical trials referenced in this review were registered with the UMIN in Japan and each registration number was stated in each published paper. Our research was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}